Rogers Yongqing Luo
Tracked across 1 events · 8 articles · First seen Jun 26, 2026 · Last active Jun 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Mr. Rogers Yongqing Luo, CEO of Everest Medicines, highlighted the significance of the BLA acceptance for Lerociclib's commercialization in Greater China and its potential to address unmet medical needs.
Jun 26, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Rogers Yongqing Luo live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard